OBJECTIVES: The goal of this study was to describe our 3-step approach to treat multisegmental thoraco-abdominal aortic disease due to aortic dissection and to present our initial clinical results. METHODS: Nine patients with multisegmental thoraco-abdominal aortic pathology due to aortic dissection underwent our 3-step approach, which consisted of total aortic arch replacement via the frozen elephant trunk technique, thoracic endovascular aortic repair for distal extension down to the level of the thoraco-abdominal transition and, finally, open thoraco-abdominal aortic replacement for the remaining downstream aortic segments. We assessed their baseline and aortic characteristics, previous aortic procedures, intraoperative details, clinical outcomes and follow-up data. RESULTS: The median age was 58 (42-66) years; 4 patients (44%) presented connective tissue disease. Eight patients (89%) had undergone previous aortic surgery for aortic dissection. In-hospital mortality was 0% (n = 0). None suffered symptomatic spinal cord injury or disabling stroke. During the follow-up period, 1 patient died of acute biliary septic shock 6 months after thoraco-abdominal aortic replacement. CONCLUSIONS: The 3-step approach to treat multisegmental thoraco-abdominal aortic pathology due to aortic dissection, which involves applying both open and endovascular techniques, is associated with an excellent clinical outcome and low perioperative risk. Distal shifting of the disease process through the thoracic endovascular aortic repair extension-and thereby necessitating limited open thoraco-abdominal aortic repair-seems to be the major factor enabling these favourable results. IRB APPROVAL: IRB approval was obtained (No. 425/15) from the institutional review board of the University of Freiburg.
OBJECTIVES: The goal of this study was to describe our 3-step approach to treat multisegmental thoraco-abdominal aortic disease due to aortic dissection and to present our initial clinical results. METHODS: Nine patients with multisegmental thoraco-abdominal aortic pathology due to aortic dissection underwent our 3-step approach, which consisted of total aortic arch replacement via the frozen elephant trunk technique, thoracic endovascular aortic repair for distal extension down to the level of the thoraco-abdominal transition and, finally, open thoraco-abdominal aortic replacement for the remaining downstream aortic segments. We assessed their baseline and aortic characteristics, previous aortic procedures, intraoperative details, clinical outcomes and follow-up data. RESULTS: The median age was 58 (42-66) years; 4 patients (44%) presented connective tissue disease. Eight patients (89%) had undergone previous aortic surgery for aortic dissection. In-hospital mortality was 0% (n = 0). None suffered symptomatic spinal cord injury or disabling stroke. During the follow-up period, 1 patient died of acute biliary septic shock 6 months after thoraco-abdominal aortic replacement. CONCLUSIONS: The 3-step approach to treat multisegmental thoraco-abdominal aortic pathology due to aortic dissection, which involves applying both open and endovascular techniques, is associated with an excellent clinical outcome and low perioperative risk. Distal shifting of the disease process through the thoracic endovascular aortic repair extension-and thereby necessitating limited open thoraco-abdominal aortic repair-seems to be the major factor enabling these favourable results. IRB APPROVAL: IRB approval was obtained (No. 425/15) from the institutional review board of the University of Freiburg.
Authors: Martin Czerny; Holger Eggebrecht; Herve Rousseau; Paul Revel Mouroz; Rolf-Alexander Janosi; Mario Lescan; Christian Schlensak; Dittmar Böckler; Marius Ante; Emma Vdr Weijde; Robin Heijmen; Hans Henning Eckstein; Benedikt Reutersberg; Santi Trimarchi; Jürg Schmidli; Thomas Wyss; Romina Frey; Vladimir Makaloski; Jan Brunkwall; Spyridon Mylonas; Zoltan Szeberin; Josef Klocker; Roman Gottardi; Ingrid Schusterova; Julia Morlock; Tim Berger; Friedhelm Beyersdorf; Bartosz Rylski Journal: Ann Thorac Surg Date: 2020-04-10 Impact factor: 4.330
Authors: Christian D Etz; Fabian A Kari; Christoph S Mueller; Daniel Silovitz; Robert M Brenner; Hung-Mo Lin; Randall B Griepp Journal: J Thorac Cardiovasc Surg Date: 2011-04 Impact factor: 5.209
Authors: Tim Berger; Maximilian Kreibich; Bartosz Rylski; Julia Morlock; Stoyan Kondov; Johannes Scheumann; Fabian A Kari; Klaus Staier; Sven Maier; Friedhelm Beyersdorf; Martin Czerny; Matthias Siepe Journal: J Cardiovasc Surg (Torino) Date: 2019-07-12 Impact factor: 1.888
Authors: Maximilian Kreibich; Dennis Bünte; Tim Berger; Andreas Vötsch; Bartosz Rylski; Philipp Krombholz-Reindl; Zehang Chen; Julia Morlock; Friedhelm Beyersdorf; Andreas Winkler; Bernd Rolauffs; Matthias Siepe; Roman Gottardi; Martin Czerny Journal: Ann Thorac Surg Date: 2020-03-16 Impact factor: 4.330
Authors: Maximilian Kreibich; Tim Berger; Tim Walter; Paul Potratz; Philipp Discher; Stoyan Kondov; Friedhelm Beyersdorf; Matthias Siepe; Roman Gottardi; Martin Czerny; Bartosz Rylski Journal: Cardiovasc Diagn Ther Date: 2022-06
Authors: Tim Berger; Miriam Graap; Bartosz Rylski; Albi Fagu; Roman Gottardi; Tim Walter; Philipp Discher; Muhammad Taha Hagar; Stoyan Kondov; Martin Czerny; Maximilian Kreibich Journal: Front Cardiovasc Med Date: 2022-06-06
Authors: Tim Walter; Tim Berger; Stoyan Kondov; Roman Gottardi; Julia Benk; Bartosz Rylski; Martin Czerny; Maximilian Kreibich Journal: Front Cardiovasc Med Date: 2022-06-30
Authors: Stoyan Kondov; Leon Frankenberger; Matthias Siepe; Cornelius Keyl; Klaus Staier; Frank Humburger; Bartosz Rylski; Maximilian Kreibich; Tim Berger; Friedhelm Beyersdorf; Martin Czerny Journal: Interact Cardiovasc Thorac Surg Date: 2022-08-03